Enhancing industry-based dissemination of an occupational sun protection program with theory-based strategies employing personal contact
Abstract
PURPOSE: Industry-based strategies for dissemination of an evidence-based occupational sun protection program, Go Sun Smart (GSS), were tested.
DESIGN: Two dissemination strategies were compared in a randomized trial in 2004-2007.
SETTING: The North American ski industry.
SUBJECTS: Ski areas in the United States and Canada (n = 69) and their senior managers (n = 469).
INTERVENTION: Employers received GSS through a basic dissemination strategy (BDS) from the industry's professional association that included conference presentations and free starter kits. Half of the areas also received the enhanced dissemination strategy (EDS), in which project staff met face-to-face with managers and made ongoing contacts to support program use.
MEASURES: Observation of program materials in use and managers' reports on communication about sun protection.
ANALYSIS: The effects of two alternative dissemination strategies were compared on program use using PROC MIXED in SAS, adjusted for covariates using one-tailed p values.
RESULTS: Ski areas receiving the EDS used more GSS materials (x¯ = 7.36) than those receiving the BDS (x¯ = 5.17; F = 7.82, p < .01). Managers from more areas receiving the EDS reported communicating about sun protection in employee newsletters/flyers (x¯ = .97, p = .04), in guest e-mail messages (x¯ = .75, p = .02), and on ski area Web sites (x¯ = .38, p = .02) than those receiving the BDS (x¯ = .84, .50, .15, respectively).
CONCLUSION: Industry professional associations…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 469 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.